PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
PARP Inhibitors for Recurrent Ovarian Cancer: Leveraging the Latest Tools in the Therapeutic Toolbox to Improve Patient Outcomes
Visit https://www.peervoice.com/HGZ860 to view the entire programme with slides. After completing “PARP Inhibitors for Recurrent Ovarian Cancer: Leveraging the Latest Tools in the Therapeutic Toolbox to Improve Patient Outcomes”, participants will be able to: Evaluate the latest data on the use of PARP inhibitors for the management of recurrent ovarian cancer (ROC); Formulate personalized strategies for managing patients with ROC, based on current clinical evidence and patient characteristics.